Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Six months after the publication of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequence, a record number of vaccine candidates were listed, and quite a number of them have since been approved for emergency use against the novel coronavirus disease 2019 (COVID-19). This unpreced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyei-Barffour, Isaac, Addo, Samuel Akwetey, Aninagyei, Enoch, Ghartey-Kwansah, George, Acheampong, Desmond Omane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486642/
https://www.ncbi.nlm.nih.gov/pubmed/34624675
http://dx.doi.org/10.1016/j.biopha.2021.112282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486642/
https://www.ncbi.nlm.nih.gov/pubmed/34624675
http://dx.doi.org/10.1016/j.biopha.2021.112282

Ejemplares similares